June 20, 2024
340B and The Likely Path Forward
After 340B Hearing and New Bills Emerging; The Likely Path Forward By Ted Slafsky Despite its importance, the 340B drug discount program rarely ever goes under the Congressional spotlight. In fact, until the June 4th House Energy & Commerce (E&C) Oversight and Investigations Subcommittee hearing, there had not been a hearing specifically devoted to the […]